See more : DNI Metals Inc. (DMNKF) Income Statement Analysis – Financial Results
Complete financial analysis of Cawachi Limited (2664.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cawachi Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- AddLife AB (publ) (ADDLF) Income Statement Analysis – Financial Results
- Enedo Oyj (ENEDO.HE) Income Statement Analysis – Financial Results
- Bombardier Inc. (0QZP.L) Income Statement Analysis – Financial Results
- MTU Aero Engines AG (MTUAY) Income Statement Analysis – Financial Results
- Artivion, Inc. (CRY) Income Statement Analysis – Financial Results
Cawachi Limited (2664.T)
About Cawachi Limited
Cawachi Limited manages drugstores in Japan. The company retails pharmaceuticals, health foods, childcare products, cosmetics, daily miscellaneous goods, general food products, confectionery products, etc. It also involved in the insurance business. The company operates 355 drugstores. Cawachi Limited was founded in 1967 and is headquartered in Oyama, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 285.96B | 281.87B | 279.46B | 284.49B | 270.31B | 264.93B | 268.21B | 266.42B | 260.62B | 258.32B | 242.68B | 231.66B | 222.32B | 235.53B | 232.30B | 233.96B | 224.65B | 207.34B | 200.16B | 193.86B |
Cost of Revenue | 220.16B | 217.82B | 216.31B | 219.81B | 211.60B | 207.73B | 211.07B | 209.60B | 205.44B | 204.14B | 189.93B | 180.36B | 170.65B | 185.44B | 182.87B | 184.99B | 175.73B | 178.58B | 156.75B | 151.44B |
Gross Profit | 65.80B | 64.05B | 63.15B | 64.68B | 58.71B | 57.20B | 57.14B | 56.83B | 55.18B | 54.18B | 52.75B | 51.29B | 51.67B | 50.09B | 49.43B | 48.97B | 48.92B | 28.76B | 43.41B | 42.42B |
Gross Profit Ratio | 23.01% | 22.72% | 22.60% | 22.73% | 21.72% | 21.59% | 21.30% | 21.33% | 21.17% | 20.97% | 21.74% | 22.14% | 23.24% | 21.27% | 21.28% | 20.93% | 21.78% | 13.87% | 21.69% | 21.88% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.98B | 2.30B | 1.83B |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.58B | 2.29B | 2.18B |
SG&A | 53.99B | 53.18B | 51.12B | 49.76B | 48.57B | 48.52B | 47.79B | 46.40B | 45.65B | 46.56B | 41.11B | 38.40B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.56B | 4.59B | 4.00B |
Other Expenses | 4.21B | 1.14B | 1.08B | 1.12B | 1.01B | 1.81B | 1.70B | 1.60B | 1.56B | 1.33B | 1.26B | 999.00M | 817.00M | 750.00M | 776.00M | 849.00M | 597.00M | 455.00M | 494.00M | 552.00M |
Operating Expenses | 58.20B | 57.44B | 55.44B | 54.12B | 53.04B | 53.31B | 52.56B | 51.10B | 50.53B | 51.36B | 45.57B | 43.08B | 41.63B | 42.09B | 42.02B | 41.18B | 38.48B | 32.61B | 29.50B | 27.21B |
Cost & Expenses | 278.36B | 275.26B | 271.75B | 273.93B | 264.64B | 261.04B | 263.63B | 260.70B | 255.97B | 255.50B | 235.50B | 223.44B | 212.28B | 227.53B | 224.89B | 226.17B | 214.21B | 211.19B | 186.26B | 178.65B |
Interest Income | 19.00M | 21.00M | 24.00M | 28.00M | 32.00M | 36.00M | 40.00M | 42.00M | 45.00M | 45.00M | 43.00M | 45.00M | 48.00M | 49.00M | 46.00M | 44.00M | 34.00M | 30.00M | 24.00M | 17.00M |
Interest Expense | 35.00M | 41.00M | 49.00M | 61.00M | 68.00M | 79.00M | 101.00M | 130.00M | 170.00M | 224.00M | 220.00M | 270.00M | 329.00M | 394.00M | 449.00M | 482.00M | 466.00M | 398.00M | 424.00M | 535.00M |
Depreciation & Amortization | 4.31B | 4.35B | 4.42B | 4.47B | 4.59B | 5.15B | 5.15B | 5.10B | 5.31B | 5.20B | 4.57B | 4.68B | 4.86B | 5.03B | 5.50B | 5.42B | 4.88B | 4.83B | 4.73B | 4.65B |
EBITDA | 11.50B | 10.90B | 12.07B | 14.96B | 10.18B | 8.89B | 9.56B | 10.65B | 9.75B | 1.97B | 11.64B | 10.84B | 14.10B | 12.33B | 13.02B | 13.53B | 15.68B | 14.71B | 12.22B | 17.69B |
EBITDA Ratio | 4.02% | 4.30% | 4.74% | 5.69% | 4.19% | 4.11% | 4.28% | 4.68% | 4.44% | 3.64% | 5.38% | 6.02% | 7.09% | 5.87% | 5.91% | 6.03% | 7.10% | 8.39% | 9.57% | 10.54% |
Operating Income | 7.60B | 6.61B | 7.71B | 10.56B | 5.68B | 3.89B | 4.57B | 5.72B | 4.66B | 2.81B | 7.18B | 8.21B | 10.04B | 8.00B | 7.41B | 7.79B | 10.44B | 9.59B | 11.10B | 12.61B |
Operating Income Ratio | 2.66% | 2.35% | 2.76% | 3.71% | 2.10% | 1.47% | 1.71% | 2.15% | 1.79% | 1.09% | 2.96% | 3.54% | 4.52% | 3.40% | 3.19% | 3.33% | 4.65% | 4.63% | 5.55% | 6.50% |
Total Other Income/Expenses | -448.00M | -39.00M | -22.00M | 76.00M | 107.00M | -52.00M | 1.21B | 147.00M | -721.00M | -6.26B | -1.99B | -2.33B | -1.12B | -1.09B | -349.00M | 17.00M | -103.00M | -107.00M | -4.04B | -109.00M |
Income Before Tax | 7.15B | 6.57B | 7.69B | 10.64B | 5.78B | 3.83B | 5.79B | 5.87B | 3.94B | -3.45B | 5.19B | 5.89B | 8.92B | 6.91B | 7.06B | 7.81B | 10.34B | 9.48B | 7.07B | 12.50B |
Income Before Tax Ratio | 2.50% | 2.33% | 2.75% | 3.74% | 2.14% | 1.45% | 2.16% | 2.20% | 1.51% | -1.34% | 2.14% | 2.54% | 4.01% | 2.93% | 3.04% | 3.34% | 4.60% | 4.57% | 3.53% | 6.45% |
Income Tax Expense | 2.44B | 2.39B | 2.86B | 3.53B | 1.96B | 1.82B | 1.92B | 2.36B | 1.96B | 1.22B | 3.18B | 3.82B | 4.50B | 3.11B | 3.37B | 5.31B | 4.45B | 4.00B | 2.91B | 5.31B |
Net Income | 4.71B | 4.18B | 4.83B | 7.11B | 3.82B | 2.02B | 3.87B | 3.51B | 1.98B | -4.67B | 2.02B | 2.07B | 4.42B | 3.80B | 3.69B | 2.50B | 5.89B | 5.48B | 4.15B | 7.19B |
Net Income Ratio | 1.65% | 1.48% | 1.73% | 2.50% | 1.41% | 0.76% | 1.44% | 1.32% | 0.76% | -1.81% | 0.83% | 0.89% | 1.99% | 1.61% | 1.59% | 1.07% | 2.62% | 2.64% | 2.07% | 3.71% |
EPS | 211.02 | 187.02 | 216.41 | 318.73 | 170.34 | 88.40 | 169.71 | 153.47 | 85.39 | -202.09 | 87.16 | 88.01 | 185.22 | 157.16 | 150.16 | 101.78 | 239.48 | 223.08 | 169.31 | 290.45 |
EPS Diluted | 210.78 | 186.81 | 216.04 | 318.48 | 170.22 | 88.38 | 169.71 | 153.40 | 85.34 | -202.09 | 87.08 | 87.99 | 185.22 | 157.16 | 150.16 | 101.78 | 239.48 | 223.08 | 169.31 | 289.87 |
Weighted Avg Shares Out | 22.33M | 22.33M | 22.32M | 22.30M | 22.44M | 22.80M | 22.80M | 22.87M | 23.13M | 23.12M | 23.12M | 23.48M | 23.85M | 24.18M | 24.58M | 24.58M | 24.58M | 24.58M | 24.53M | 24.50M |
Weighted Avg Shares Out (Dil) | 22.36M | 22.36M | 22.36M | 22.32M | 22.45M | 22.81M | 22.80M | 22.88M | 23.14M | 23.12M | 23.14M | 23.48M | 23.85M | 24.18M | 24.58M | 24.58M | 24.58M | 24.58M | 24.53M | 24.81M |
Source: https://incomestatements.info
Category: Stock Reports